Today: 20 January 2026
Subscribe
Browse Category

Stock Market News 7 December 2025

KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

Updated: December 7, 2025 – Ticker: KULR (NYSE American) KULR Stock Snapshot: Price, Market Cap, and Volatility At the start of December 2025, KULR Technology Group’s share price is hovering around $3.93, with recent trading showing an intraday range between roughly $3.78 and $3.99 and volume around 1.36 million shares. That puts the company’s market capitalization near $180 million. Stock…
7 December 2025
····
BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP stock is ending the first week of December in a strange but familiar place: cash is pouring out to shareholders, the share price is recovering, analysts are split, and the long‑term energy transition story is getting messier. As of the close on 5 December 2025, BP’s New York–listed ADRs (NYSE: BP) traded around $35.8 per share, while the London‑listed…
7 December 2025
····
Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Published: December 7, 2025 Nike’s stock has had a choppy 2025, and as of early December the story is less about sneakers and more about strategy: a leadership overhaul, pressure in China, a fresh dividend increase and a market still trying to decide whether NKE is a turnaround play or a value trap. Nike (NKE) Stock Price Snapshot Today Nike’s…
7 December 2025
···
StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

StockX Stock in 2025: Price, Valuation, IPO Hopes and How Investors Can (Actually) Get Exposure

As of December 7, 2025, sneakerheads, collectors and private‑market investors are all watching the same thing: “StockX stock”—even though the company still isn’t publicly listed on any exchange. StockX, the Detroit‑based marketplace that brands itself as the “stock market of things,” remains a private, venture‑backed company. But a growing ecosystem of pre‑IPO platforms, secondary brokers and data providers now publishes…
7 December 2025
····
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Updated: December 7, 2025 Merck & Co., Inc. (NYSE: MRK) — the U.S. pharmaceutical company behind blockbuster cancer drug Keytruda and HPV vaccine Gardasil — has just wrapped up a busy early-December news cycle. The company closed a multi‑billion‑dollar debt offering, secured fresh regulatory wins in its cardiopulmonary and animal-health franchises, boosted its dividend, and simultaneously ran into a new…
7 December 2025
····
Dow Jones Near 48,000: Fed Rate Cut Bets and 2026 Stock Market Outlook

Dow Jones Near 48,000: Fed Rate Cut Bets and 2026 Stock Market Outlook

Published: December 7, 2025 As the first full week of December wraps up, the Dow Jones Industrial Average is pressing up against the 48,000 line, sitting within striking distance of its all‑time highs. Investors are simultaneously cheering cooling inflation and a coming Federal Reserve rate cut, while parsing a thicket of 2026 forecasts that range from “bull market continues” to…
7 December 2025
····
IWM Stock Forecast: Is the iShares Russell 2000 ETF Poised for a 2026 Small‑Cap Rally?

IWM Stock Forecast: Is the iShares Russell 2000 ETF Poised for a 2026 Small‑Cap Rally?

As of December 7, 2025 The iShares Russell 2000 ETF (ticker: IWM) is back near its highs, trading around $250.77 after a powerful rebound in U.S. small‑cap stocks. The fund now sits close to its 52‑week peak near $252, up in the mid‑teens on a year‑to‑date basis, and well above its 52‑week low near $172. Investing At the same time,…
7 December 2025
···
Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

As of 7 December 2025, Upstart Holdings (NASDAQ: UPST) sits right back in the market’s spotlight. The AI-powered consumer lender has delivered its strongest growth in years, secured multi‑billion‑dollar funding lines, and returned to GAAP profitability – yet its stock remains volatile, heavily shorted, and hotly debated on Wall Street. AlphaSense This article rounds up the latest Upstart stock news,…
7 December 2025
····
AbbVie Stock (ABBV) Today: Price, Dividend Hike, Pipeline Catalysts and 2025–2026 Outlook

AbbVie Stock (ABBV) Today: Price, Dividend Hike, Pipeline Catalysts and 2025–2026 Outlook

AbbVie’s stock is trading just below record highs as investors digest a powerful mix of rising earnings, a fresh dividend increase and a steady drumbeat of positive pipeline news in immunology, neuroscience and oncology. As of the close on Friday, December 5, 2025, AbbVie (NYSE: ABBV) finished at $226.08, down about 1.15% on the day and roughly 7–8% below its…
7 December 2025
····
Caterpillar (CAT) Stock on December 7, 2025: Record Highs, AI Tailwinds and 2026 Forecasts

Caterpillar (CAT) Stock on December 7, 2025: Record Highs, AI Tailwinds and 2026 Forecasts

Caterpillar Inc. (NYSE: CAT) goes into December 7, 2025 as one of the surprise “AI winners” of the year — even though it makes machines that move rock and dirt, not lines of code. The stock is trading a little above $600 per share, around $603, hovering near its record highs in the low $600s. Over the past year, CAT…
7 December 2025
····
Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Novo Nordisk Stock (NVO) in December 2025: Alzheimer’s Failure, GLP‑1 Price Cuts and 2026 Turnaround Hopes

Updated December 7, 2025 – for information only, not investment advice. Novo Nordisk stock today: from market darling to turnaround story Novo Nordisk (NYSE: NVO), the Danish giant behind GLP‑1 blockbusters Wegovy and Ozempic, has gone from Europe’s most valuable listed company to a bruised turnaround story in 2025. For investors, NVO has abruptly shifted from a “can do no…
7 December 2025
····
Visa Stock (V) Outlook as of December 7, 2025: HQ Move, AI PayLater Card and Legal Risks Shape 2026 Forecast

Visa Stock (V) Outlook as of December 7, 2025: HQ Move, AI PayLater Card and Legal Risks Shape 2026 Forecast

Published: December 7, 2025 Visa Inc. (NYSE: V) is trading around $331 per share as of early December 2025, roughly 12% below its 2025 high near $375 and about 11% above its 52‑week low around $299. With a market value in the mid‑$600 billion range and trailing revenue of $40 billion, the payments giant remains one of the most profitable…
7 December 2025
····
1 … 1,002 1,003 1,004 1,005 1,006 … 1,486

Stock Market Today

  • SiteOne Landscape Supply (SITE) Valuation Review Amid Recent Stock Gains
    January 19, 2026, 9:26 PM EST. SiteOne Landscape Supply (SITE) shares have shown strong momentum with a 14.8% gain over 30 days and 20.3% over 90 days, despite a 1.5% pullback in the last day. The stock currently trades at $147.53, close to an average analyst target of $155. A fair value estimate of $156.40 suggests the stock may be undervalued, backed by assumptions of steady revenue growth, rising profit margins, and future earnings multiples above current industry levels. However, SITE's high price-to-earnings ratio of 47x versus industry peers at 17.2x reflects elevated investor expectations. Risks include heavy reliance on acquisitions and sensitivity to construction sector trends, which could affect margin and earnings forecasts.
Go toTop